The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
This story is going from strength to strength and goes to prove how disconnected the stock market is on a daily basis from a company true valuation. But at the end of the day good companies perform just have to wait
The technology is niche and key to big pharmas, also have faith and trust in Adam Hill to deliver.Partnerships and contracts take time to finalise. Personalised medicine is massive and isn’t going away and will save pharmas millions. Also like mention before this is primed for a buy out
So people were happy to hold this at £2 and not sell but now selling it at £1.55 when the company is exactly the same all because you can’t handle a rough patch. I strongly advise doing something else with your money and save yourself a lot of hassle. Daft!!